Figure 3.
Comparison of (A) response/remission of platelet count and (B) bleeding control between the stepwise group and the thrombopoietin receptor agonist (TPO-RA) group at 6 and 12 months. Due to the loss of follow-up, only 109 participants in the stepwise group were available for analysis after 12 months. While in the TPO-RA group, 30 participants remained available after 6 months and 21 after 12 months.
